During the past decade, Columbia University Arsenic Research Project conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia University Arsenic Research Project" #1 collaborator was "Columbia University" with 1 trials as a collaborator, "Dartmouth-Hitchcock Medical Center" with 1 trials as a collaborator, "International Centre for Diarrhoeal Disease Research, Bangladesh" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Columbia University Arsenic Research Project" are "Arsenic Metabolites Measured in Urine" (1 trials), "High Blood Arsenic Due to Chronic Arsenic Exposure" (1 trials) and "Non-melanoma Skin Cancer" (1 trials). Many other conditions were trialed in "Columbia University Arsenic Research Project" in a lesser frequency.

Most popular intervention types in "Columbia University Arsenic Research Project" are "Dietary Supplement" (2 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Betaine" (1 trials), "Choline bitartrate" (1 trials), "Choline bitartrate + Betaine" (1 trials) and "Selenium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbia University Arsenic Research Project" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Columbia University Arsenic Research Project". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Columbia University Arsenic Research Project, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Columbia University Arsenic Research Project, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Columbia University Arsenic Research Project has several departments that took part in Clinical trials: "Columbia University Global Health Research Center of Central Asia" - 6 trials